EMAIL THIS PAGE TO A FRIEND

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Safety and efficacy of ibutilide in heart transplant recipients.


PMID 19416781

Abstract

In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

I9910
Ibutilide hemifumarate salt, ≥98% (HPLC)
C20H36N2O3S · 0.5C4H4O4